NEW YORK (GenomeWeb) – Personal Genome Diagnostics and Human Longevity today announced they have signed a collaborative agreement to provide genomic sequencing services to each other.

Human Longevity will have access to PGDx cancer genome analysis panels including CancerSelect, PlasmaSelectCancerXome, METDetec, and CancerComplete. It has also licensed the PGDx Enterprise Solution platform, which enables laboratories to conduct their own advanced cancer genomic testing using next-generation sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.